Apr. 30, 2020—A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup.
Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.
Mar. 31, 2016—A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.
Feb. 6, 2014—Healthcare Informatics Magazine has awarded Vanderbilt University Medical Center third place in its 2014 Innovator Awards.
Oct. 17, 2013—A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions.
Nov. 8, 2012—Joshua Denny, M.D., M.S., assistant professor of Biomedical Informatics and Medicine and a key contributor to Vanderbilt University’s personalized medicine initiative, is the 2012 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).
Oct. 4, 2012—When O.T. Hayes, 67, of Lebanon, Tenn., first starting seeing his cardiologist, David Hansen, M.D., for treatment of his coronary artery disease, it was hard to predict which of the various medications available would help control Haynes’ high cholesterol.